How accurate are blood (or breath) tests for identifying self-reported heavy drinking among people with alcohol dependence?

Alcohol and Alcoholism

Volumn 49, Issue 4, 2014, Pages 423-429

  Bertholet, Nicolas ^a   Winter, Michael R ^b   Cheng, Debbie M ^b,c   Samet, Jeffrey H ^b,c   Saitz, Richard ^b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^c BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BIOLOGICAL MARKER; DISIALO CARBOHYDRATE DEFICIENT TRANSFERRIN; GAMMA GLUTAMYLTRANSFERASE; TRANSFERRIN; UNCLASSIFIED DRUG; DISIALOTRANSFERRIN; SIALOGLYCOPROTEIN;

ACCURACY; ADULT; ALCOHOL CONSUMPTION; ALCOHOLISM; ARTICLE; BLOOD ANALYSIS; BREATH ANALYSIS; DRINKING BEHAVIOR; FEMALE; HEAVY DRINKING; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SELF REPORT; YOUNG ADULT; ANALOGS AND DERIVATIVES; BLOOD; BLOOD EXAMINATION; CROSS-SECTIONAL STUDY; PREDICTIVE VALUE; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; UNITED STATES;

ADULT; ALCOHOL DRINKING; ALCOHOLISM; BIOLOGICAL MARKERS; BOSTON; BREATH TESTS; CROSS-SECTIONAL STUDIES; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HEMATOLOGIC TESTS; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; SELF REPORT; SENSITIVITY AND SPECIFICITY; SIALOGLYCOPROTEINS; TRANSFERRIN; YOUNG ADULT;

EID: 84902504709     PISSN: 07350414     EISSN: 14643502     Source Type: Journal    
DOI: 10.1093/alcalc/agu016     Document Type: Article

References (44)

1. Allen JP, Litten RZ, Fertig JB et al. (2001) Carbohydrate-deficient transferrin: an aid to early recognition of alcohol relapse. Am J Addict 10(Suppl):24-8.
2. Altman DG, Gardner MJ. (1992) Confidence intervals for research findings. Br J Obstet Gynaecol 99:90-1.
3. Anton RF. (2001) Carbohydrate-deficient transferrin for detection and monitoring of sustained heavy drinking. What have we learned? Where do we go from here? Alcohol 25:185-8.
4. Anton RF, Lieber C, TabakoffB. (2002) Carbohydrate-deficient transferrin and gamma-glutamyltransferase for the detection and monitoring of alcohol use: results from a multisite study. Alcohol Clin Exp Res 26:1215-22.
5. Anttila P, Jarvi K, Latvala J et al. (2003) A new modified gamma-% CDT method improves the detection of problem drinking: studies in alcoholics with or without liver disease. Clin Chim Acta 338:45-51.
6. Arndt T. (2001) Carbohydrate-deficient transferrin as a marker of chronic alcohol abuse: a critical review of preanalysis, analysis, and interpretation. Clin Chem 47:13-27.
7. Arndt T, Meier U, Nauck M et al. (2006) Primary biliary cirrhosis is not a clinical condition for increased carbohydrate-deficient transferrin: experience with four independent CDT analysis methods. Clin Chim Acta 372:184-7.
8. Bortolotti F, De Paoli G, Tagliaro F. (2006) Carbohydrate-deficient transferrin (CDT) as a marker of alcohol abuse: a critical review of the literature 2001-2005. J Chromatogr B Analyt Technol Biomed Life Sci 841:96-109.
9. Burke V, Puddey IB, Rakic V et al. (1998) Carbohydrate-deficient transferrin as a marker of change in alcohol intake in men drinking 20 to 60 g of alcohol per day. Alcohol Clin Exp Res 22:1973-80.
10. Carey KB, Carey MP, Maisto SA et al. (2004) Temporal stability of the timeline followback interview for alcohol and drug use with psychiatric outpatients. J Stud Alcohol 65:774-81.
11. Conigrave KM, Degenhardt LJ, Whitfield JB et al. (2002) CDT, GGT, and AST as markers of alcohol use: the WHO/ISBRA collaborative project. Alcohol Clin Exp Res 26:332-9.
12. Fals-Stewart W, O'Farrell TJ, Freitas TT et al. (2000) The timeline followback reports of psychoactive substance use by drug-abusing patients: psychometric properties. J Consult Clin Psychol 68:134-44.
13. Fleming MF, Anton RF, Spies CD. (2004) A review of genetic, biological, pharmacological, and clinical factors that affect carbohydrate-deficient transferrin levels. Alcohol Clin Exp Res 28:1347-55.
14. Folstein MF, Folstein SE, McHugh PR. (1975) 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-98.
15. Golka K, Wiese A. (2004) Carbohydrate-deficient transferrin (CDT) -a biomarker for long-term alcohol consumption. J Toxicol Environ Health B Crit Rev 7:319-37.
16. Grant KA, Tonigan JS, Miller WR. (1995) Comparison of three alcohol consumption measures: a concurrent validity study. J Stud Alcohol 56:168-72.
17. Hannuksela ML, Liisanantti MK, Nissinen AE et al. (2007) Biochemical markers of alcoholism. Clin Chem Lab Med 45:953-61.
18. Helander A, Peter O, Zheng Y. (2012) Monitoring of the alcohol biomarkers PEth, CDT and EtG/EtS in an outpatient treatment setting. Alcohol Alcohol 47:552-7.
19. Jaeschke R, Guyatt GH, Sackett DL. (1994) Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. JAMA 271:703-7.
20. Johnson-Greene D, McCaul ME, Roger P. (2009) Screening for hazardous drinking using the Michigan Alcohol Screening Test-Geriatric Version (MAST-G) in elderly persons with acute cerebrovascular accidents. Alcohol Clin Exp Res 33:1555-61.
21. Katz JN, Chang LC, Sangha O et al. (1996) Can comorbidity be measured by questionnaire rather than medical record review? Med Care 34:73-84.
22. Kharbouche H, Faouzi M, Sanchez N et al. (2012) Diagnostic performance of ethyl glucuronide in hair for the investigation of alcohol drinking behavior: a comparison with traditional biomarkers. Int J Legal Med 126:243-50.
23. Koch H, Meerkerk GJ, Zaat JO et al. (2004) Accuracy of carbohydrate-deficient transferrin in the detection of excessive alcohol consumption: a systematic review. Alcohol Alcohol 39:75-85.
24. McLellan AT. (2002) Have we evaluated addiction treatment correctly? Implications from a chronic care perspective. Addiction 97:249-52.
25. McLellan AT, Kushner H, Metzger D et al. (1992) The Fifth Edition of the Addiction Severity Index. J Subst Abuse Treat 9:199-213.
26. McLellan AT, Lewis DC, O'Brien CP et al. (2000) Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA 284:1689-95.
27. Mitchell C, Simpson D, Chick J. (1997) Carbohydrate deficient transferrin in detecting relapse in alcohol dependence. Drug Alcohol Depend 48:97-103.
28. Neumann T, Spies C. (2003) Use of biomarkers for alcohol use disorders in clinical practice. Addiction 98(Suppl 2):81-91.
29. Nyblom H, Berggren U, Balldin J et al. (2004) High AST/ALT ratio may indicate advanced alcoholic liver disease rather than heavy drinking. Alcohol Alcohol 39:336-9.
30. Saitz R, Larson MJ, Labelle C et al. (2008) The case for chronic disease management for addiction. J Addict Med 2:55-65.
31. Saitz R, Cheng DM, Winter M et al. (2013) Chronic care management for dependence on alcohol and other drugs: the AHEAD randomized trial. JAMA 310:1156-67.
32. Salaspuro M. (1987) Use of enzymes for the diagnosis of alcoholrelated organ damage. Enzyme 37:87-107.
33. Salaspuro M. (1999) Carbohydrate-deficient transferrin as compared to other markers of alcoholism: a systematic review. Alcohol 19:261-71.
34. Schellenberg F, Schwan R, Mennetrey L et al. (2005) Dose-effect relation between daily ethanol intake in the range 0-70 grams and %CDT value: validation of a cut-offvalue. Alcohol Alcohol 40:531-4.
35. Schwan R, Albuisson E, Malet L et al. (2004) The use of biological laboratory markers in the diagnosis of alcohol misuse: an evidence-based approach. Drug Alcohol Depend 74:273-9.
36. Seale JP, Boltri JM, Shellenberger S et al. (2006) Primary care validation of a single screening question for drinkers. J Stud Alcohol 67:778-84.
37. Sillanaukee P, Olsson U. (2001) Improved diagnostic classification of alcohol abusers by combining carbohydrate-deficient transferrin and gamma-glutamyltransferase. Clin Chem 47:681-5.
38. Sillanaukee P, Massot N, Jousilahti P et al. (2000) Dose response of laboratory markers to alcohol consumption in a general population. Am J Epidemiol 152:747-51.
39. Smith KL, Horton NJ, Saitz R et al. (2006) The use of the minimental state examination in recruitment for substance abuse research studies. Drug Alcohol Depend 82:231-7.
40. Sobell LC, Sobell MB. (1992) Timeline follow-back. A technique for assessing self-reported alcohol consumption. In Litten AE (ed). Measuring Alcohol Consumption: Psychosocial and Biochemical Methods. Totowa, NJ: Humana Press, 41-72.
41. Sobell LC, Sobell MB. (1995) Alcohol Timeline Followback (TLFB) Users' Manual. Toronto, Canada: Addiction Research Foundation.
42. Sobell MB, Sobell LC, Klajner F et al. (1986) The reliability of a timeline method for assessing normal drinker college students' recent drinking history: utility for alcohol research. Addict Behav 11:149-61.
43. Sobell LC, Agrawal S, Annis H et al. (2001) Cross-cultural evaluation of two drinking assessment instruments: alcohol timeline followback and inventory of drinking situations. Subst Use Misuse 36:313-31.
44. Ware J, Jr, Kosinski M, Keller SD. (1996) A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 34:220-33.